Global Nutrigenomics Market
Global Nutrigenomics Market

Nutrigenomics Comprehensive Study by Type (Reagents & kits, Services), Application (Obesity, Diabetes, Anti-Aging, Chronic Diseases), Techniques (Saliva, Buccal Swab, Blood, Others) Players and Region - Global Market Outlook to 2024

Nutrigenomics Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024 | CAGR: 5.2%  

Jun 2019 Edition 220 Pages 196 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study
Nutrigenomics is defined as basically interaction of nutrition and genes in order to the treatment of disease. It is also known as nutritional genomics. Advantages of nutrigenomics testing allow them to make positive changes to their lifestyle, shifting the focus from disease management to disease prevention and health promotion and other benefits. Introduction and development of direct to consumer nutrigenomics kits and rising intake of specialized food and diet are some of the major drivers which are propelling the growth of the market.

The market study is being classified by Type (Reagents & kits and Services), by Application (Obesity, Diabetes, Anti-Aging and Chronic Diseases) and major geographies with country level break-up. According to AMA, the Global Nutrigenomics market is expected to see growth rate of 5.2%

Cura Integrative Medicine (Australia), NutraGene (United States), XCODE Life Science Pvt. Ltd. (India), Nutrigenomix (Canada), WellGen Inc. (United States), Genomix Nutrition Inc. (United States), Royal DSM (Netherlands), BASF SE (Germany), Danone S.A (France) and GeneSmart (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Unilever (United Kingdom), Genova Diagnostics (United States), NutriGenomix, Inc. (Canada), Metagenics, Inc. (United States) and WellGen, Inc. (United States).

The market is fragmented with numerous players focusing on technique and quality of the product due to which the global nutrigenomics market can witness an upsurge in the forecast period. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Nutrigenomics market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Nutrigenomics market by Type, Application and Region.

On the basis of geography, the market of Nutrigenomics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. If we see Market by Techniques, the sub-segment i.e. Saliva will boost the Nutrigenomics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rising Healthcare Expenditure, and Encouraging Government Support for Research and Development
  • Increasing Awareness of Health and Treatments
  • Increased Spending On Healthcare and a Demand for Holistic Treatments

Market Trend
  • Technology Advancement in Nutrigenomics

Restraints
  • Issue related to High Cost Associated with the Treatment

Opportunities
  • Growing Demand from Emerging Economies such as China as well as India

Challenges
  • Lack of Physicians Qualified to Provide Nutrigenomics Treatments


Market Leaders and their expansionary development strategies
In April 2018, the Prenetics Limited (Hong Kong) Company has acquired DNAFit Ltd (United Kingdom) Company for more than USD 10 Million, which serves customers with pharmacogenomics, nutrigenomics, cancer, and reproductive health tests. Hence, this acquisition will help in strengthening the position of the company.



Key Target Audience
Nutrigenomics Testing Companies, Research and Development (R&D) Companies, Research Organization, Federal Agencies and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Reagents & kits
  • Services
By Application
  • Obesity
  • Diabetes
  • Anti-Aging
  • Chronic Diseases
By Techniques
  • Saliva
  • Buccal Swab
  • Blood
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Healthcare Expenditure, and Encouraging Government Support for Research and Development
      • 3.2.2. Increasing Awareness of Health and Treatments
      • 3.2.3. Increased Spending On Healthcare and a Demand for Holistic Treatments
    • 3.3. Market Challenges
      • 3.3.1. Lack of Physicians Qualified to Provide Nutrigenomics Treatments
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement in Nutrigenomics
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Nutrigenomics, by Type, Application, Techniques and Region (value) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Nutrigenomics (Value)
      • 5.2.1. Global Nutrigenomics by: Type (Value)
        • 5.2.1.1. Reagents & kits
        • 5.2.1.2. Services
      • 5.2.2. Global Nutrigenomics by: Application (Value)
        • 5.2.2.1. Obesity
        • 5.2.2.2. Diabetes
        • 5.2.2.3. Anti-Aging
        • 5.2.2.4. Chronic Diseases
      • 5.2.3. Global Nutrigenomics by: Techniques (Value)
        • 5.2.3.1. Saliva
        • 5.2.3.2. Buccal Swab
        • 5.2.3.3. Blood
        • 5.2.3.4. Others
      • 5.2.4. Global Nutrigenomics Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Nutrigenomics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cura Integrative Medicine (Australia)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. NutraGene (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. XCODE Life Science Pvt. Ltd. (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Nutrigenomix (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. WellGen Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Genomix Nutrition Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Royal DSM (Netherlands)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BASF SE (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Danone S.A (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. GeneSmart (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Nutrigenomics Sale, by Type, Application, Techniques and Region (value) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Nutrigenomics (Value)
      • 7.2.1. Global Nutrigenomics by: Type (Value)
        • 7.2.1.1. Reagents & kits
        • 7.2.1.2. Services
      • 7.2.2. Global Nutrigenomics by: Application (Value)
        • 7.2.2.1. Obesity
        • 7.2.2.2. Diabetes
        • 7.2.2.3. Anti-Aging
        • 7.2.2.4. Chronic Diseases
      • 7.2.3. Global Nutrigenomics by: Techniques (Value)
        • 7.2.3.1. Saliva
        • 7.2.3.2. Buccal Swab
        • 7.2.3.3. Blood
        • 7.2.3.4. Others
      • 7.2.4. Global Nutrigenomics Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Nutrigenomics: by Type(USD Million)
  • Table 2. Nutrigenomics Reagents & kits , by Region USD Million (2013-2018)
  • Table 3. Nutrigenomics Services , by Region USD Million (2013-2018)
  • Table 4. Nutrigenomics: by Application(USD Million)
  • Table 5. Nutrigenomics Obesity , by Region USD Million (2013-2018)
  • Table 6. Nutrigenomics Diabetes , by Region USD Million (2013-2018)
  • Table 7. Nutrigenomics Anti-Aging , by Region USD Million (2013-2018)
  • Table 8. Nutrigenomics Chronic Diseases , by Region USD Million (2013-2018)
  • Table 9. Nutrigenomics: by Techniques(USD Million)
  • Table 10. Nutrigenomics Saliva , by Region USD Million (2013-2018)
  • Table 11. Nutrigenomics Buccal Swab , by Region USD Million (2013-2018)
  • Table 12. Nutrigenomics Blood , by Region USD Million (2013-2018)
  • Table 13. Nutrigenomics Others , by Region USD Million (2013-2018)
  • Table 14. South America Nutrigenomics, by Country USD Million (2013-2018)
  • Table 15. South America Nutrigenomics, by Type USD Million (2013-2018)
  • Table 16. South America Nutrigenomics, by Application USD Million (2013-2018)
  • Table 17. South America Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 18. Brazil Nutrigenomics, by Type USD Million (2013-2018)
  • Table 19. Brazil Nutrigenomics, by Application USD Million (2013-2018)
  • Table 20. Brazil Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 21. Argentina Nutrigenomics, by Type USD Million (2013-2018)
  • Table 22. Argentina Nutrigenomics, by Application USD Million (2013-2018)
  • Table 23. Argentina Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 24. Rest of South America Nutrigenomics, by Type USD Million (2013-2018)
  • Table 25. Rest of South America Nutrigenomics, by Application USD Million (2013-2018)
  • Table 26. Rest of South America Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 27. Asia Pacific Nutrigenomics, by Country USD Million (2013-2018)
  • Table 28. Asia Pacific Nutrigenomics, by Type USD Million (2013-2018)
  • Table 29. Asia Pacific Nutrigenomics, by Application USD Million (2013-2018)
  • Table 30. Asia Pacific Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 31. China Nutrigenomics, by Type USD Million (2013-2018)
  • Table 32. China Nutrigenomics, by Application USD Million (2013-2018)
  • Table 33. China Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 34. Japan Nutrigenomics, by Type USD Million (2013-2018)
  • Table 35. Japan Nutrigenomics, by Application USD Million (2013-2018)
  • Table 36. Japan Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 37. India Nutrigenomics, by Type USD Million (2013-2018)
  • Table 38. India Nutrigenomics, by Application USD Million (2013-2018)
  • Table 39. India Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 40. South Korea Nutrigenomics, by Type USD Million (2013-2018)
  • Table 41. South Korea Nutrigenomics, by Application USD Million (2013-2018)
  • Table 42. South Korea Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 43. Taiwan Nutrigenomics, by Type USD Million (2013-2018)
  • Table 44. Taiwan Nutrigenomics, by Application USD Million (2013-2018)
  • Table 45. Taiwan Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 46. Australia Nutrigenomics, by Type USD Million (2013-2018)
  • Table 47. Australia Nutrigenomics, by Application USD Million (2013-2018)
  • Table 48. Australia Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 49. Rest of Asia-Pacific Nutrigenomics, by Type USD Million (2013-2018)
  • Table 50. Rest of Asia-Pacific Nutrigenomics, by Application USD Million (2013-2018)
  • Table 51. Rest of Asia-Pacific Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 52. Europe Nutrigenomics, by Country USD Million (2013-2018)
  • Table 53. Europe Nutrigenomics, by Type USD Million (2013-2018)
  • Table 54. Europe Nutrigenomics, by Application USD Million (2013-2018)
  • Table 55. Europe Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 56. Germany Nutrigenomics, by Type USD Million (2013-2018)
  • Table 57. Germany Nutrigenomics, by Application USD Million (2013-2018)
  • Table 58. Germany Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 59. France Nutrigenomics, by Type USD Million (2013-2018)
  • Table 60. France Nutrigenomics, by Application USD Million (2013-2018)
  • Table 61. France Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 62. Italy Nutrigenomics, by Type USD Million (2013-2018)
  • Table 63. Italy Nutrigenomics, by Application USD Million (2013-2018)
  • Table 64. Italy Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 65. United Kingdom Nutrigenomics, by Type USD Million (2013-2018)
  • Table 66. United Kingdom Nutrigenomics, by Application USD Million (2013-2018)
  • Table 67. United Kingdom Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 68. Netherlands Nutrigenomics, by Type USD Million (2013-2018)
  • Table 69. Netherlands Nutrigenomics, by Application USD Million (2013-2018)
  • Table 70. Netherlands Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 71. Rest of Europe Nutrigenomics, by Type USD Million (2013-2018)
  • Table 72. Rest of Europe Nutrigenomics, by Application USD Million (2013-2018)
  • Table 73. Rest of Europe Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 74. MEA Nutrigenomics, by Country USD Million (2013-2018)
  • Table 75. MEA Nutrigenomics, by Type USD Million (2013-2018)
  • Table 76. MEA Nutrigenomics, by Application USD Million (2013-2018)
  • Table 77. MEA Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 78. Middle East Nutrigenomics, by Type USD Million (2013-2018)
  • Table 79. Middle East Nutrigenomics, by Application USD Million (2013-2018)
  • Table 80. Middle East Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 81. Africa Nutrigenomics, by Type USD Million (2013-2018)
  • Table 82. Africa Nutrigenomics, by Application USD Million (2013-2018)
  • Table 83. Africa Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 84. North America Nutrigenomics, by Country USD Million (2013-2018)
  • Table 85. North America Nutrigenomics, by Type USD Million (2013-2018)
  • Table 86. North America Nutrigenomics, by Application USD Million (2013-2018)
  • Table 87. North America Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 88. United States Nutrigenomics, by Type USD Million (2013-2018)
  • Table 89. United States Nutrigenomics, by Application USD Million (2013-2018)
  • Table 90. United States Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 91. Canada Nutrigenomics, by Type USD Million (2013-2018)
  • Table 92. Canada Nutrigenomics, by Application USD Million (2013-2018)
  • Table 93. Canada Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 94. Mexico Nutrigenomics, by Type USD Million (2013-2018)
  • Table 95. Mexico Nutrigenomics, by Application USD Million (2013-2018)
  • Table 96. Mexico Nutrigenomics, by Techniques USD Million (2013-2018)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Nutrigenomics: by Type(USD Million)
  • Table 108. Nutrigenomics Reagents & kits , by Region USD Million (2019-2024)
  • Table 109. Nutrigenomics Services , by Region USD Million (2019-2024)
  • Table 110. Nutrigenomics: by Application(USD Million)
  • Table 111. Nutrigenomics Obesity , by Region USD Million (2019-2024)
  • Table 112. Nutrigenomics Diabetes , by Region USD Million (2019-2024)
  • Table 113. Nutrigenomics Anti-Aging , by Region USD Million (2019-2024)
  • Table 114. Nutrigenomics Chronic Diseases , by Region USD Million (2019-2024)
  • Table 115. Nutrigenomics: by Techniques(USD Million)
  • Table 116. Nutrigenomics Saliva , by Region USD Million (2019-2024)
  • Table 117. Nutrigenomics Buccal Swab , by Region USD Million (2019-2024)
  • Table 118. Nutrigenomics Blood , by Region USD Million (2019-2024)
  • Table 119. Nutrigenomics Others , by Region USD Million (2019-2024)
  • Table 120. South America Nutrigenomics, by Country USD Million (2019-2024)
  • Table 121. South America Nutrigenomics, by Type USD Million (2019-2024)
  • Table 122. South America Nutrigenomics, by Application USD Million (2019-2024)
  • Table 123. South America Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 124. Brazil Nutrigenomics, by Type USD Million (2019-2024)
  • Table 125. Brazil Nutrigenomics, by Application USD Million (2019-2024)
  • Table 126. Brazil Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 127. Argentina Nutrigenomics, by Type USD Million (2019-2024)
  • Table 128. Argentina Nutrigenomics, by Application USD Million (2019-2024)
  • Table 129. Argentina Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 130. Rest of South America Nutrigenomics, by Type USD Million (2019-2024)
  • Table 131. Rest of South America Nutrigenomics, by Application USD Million (2019-2024)
  • Table 132. Rest of South America Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 133. Asia Pacific Nutrigenomics, by Country USD Million (2019-2024)
  • Table 134. Asia Pacific Nutrigenomics, by Type USD Million (2019-2024)
  • Table 135. Asia Pacific Nutrigenomics, by Application USD Million (2019-2024)
  • Table 136. Asia Pacific Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 137. China Nutrigenomics, by Type USD Million (2019-2024)
  • Table 138. China Nutrigenomics, by Application USD Million (2019-2024)
  • Table 139. China Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 140. Japan Nutrigenomics, by Type USD Million (2019-2024)
  • Table 141. Japan Nutrigenomics, by Application USD Million (2019-2024)
  • Table 142. Japan Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 143. India Nutrigenomics, by Type USD Million (2019-2024)
  • Table 144. India Nutrigenomics, by Application USD Million (2019-2024)
  • Table 145. India Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 146. South Korea Nutrigenomics, by Type USD Million (2019-2024)
  • Table 147. South Korea Nutrigenomics, by Application USD Million (2019-2024)
  • Table 148. South Korea Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 149. Taiwan Nutrigenomics, by Type USD Million (2019-2024)
  • Table 150. Taiwan Nutrigenomics, by Application USD Million (2019-2024)
  • Table 151. Taiwan Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 152. Australia Nutrigenomics, by Type USD Million (2019-2024)
  • Table 153. Australia Nutrigenomics, by Application USD Million (2019-2024)
  • Table 154. Australia Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 155. Rest of Asia-Pacific Nutrigenomics, by Type USD Million (2019-2024)
  • Table 156. Rest of Asia-Pacific Nutrigenomics, by Application USD Million (2019-2024)
  • Table 157. Rest of Asia-Pacific Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 158. Europe Nutrigenomics, by Country USD Million (2019-2024)
  • Table 159. Europe Nutrigenomics, by Type USD Million (2019-2024)
  • Table 160. Europe Nutrigenomics, by Application USD Million (2019-2024)
  • Table 161. Europe Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 162. Germany Nutrigenomics, by Type USD Million (2019-2024)
  • Table 163. Germany Nutrigenomics, by Application USD Million (2019-2024)
  • Table 164. Germany Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 165. France Nutrigenomics, by Type USD Million (2019-2024)
  • Table 166. France Nutrigenomics, by Application USD Million (2019-2024)
  • Table 167. France Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 168. Italy Nutrigenomics, by Type USD Million (2019-2024)
  • Table 169. Italy Nutrigenomics, by Application USD Million (2019-2024)
  • Table 170. Italy Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 171. United Kingdom Nutrigenomics, by Type USD Million (2019-2024)
  • Table 172. United Kingdom Nutrigenomics, by Application USD Million (2019-2024)
  • Table 173. United Kingdom Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 174. Netherlands Nutrigenomics, by Type USD Million (2019-2024)
  • Table 175. Netherlands Nutrigenomics, by Application USD Million (2019-2024)
  • Table 176. Netherlands Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 177. Rest of Europe Nutrigenomics, by Type USD Million (2019-2024)
  • Table 178. Rest of Europe Nutrigenomics, by Application USD Million (2019-2024)
  • Table 179. Rest of Europe Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 180. MEA Nutrigenomics, by Country USD Million (2019-2024)
  • Table 181. MEA Nutrigenomics, by Type USD Million (2019-2024)
  • Table 182. MEA Nutrigenomics, by Application USD Million (2019-2024)
  • Table 183. MEA Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 184. Middle East Nutrigenomics, by Type USD Million (2019-2024)
  • Table 185. Middle East Nutrigenomics, by Application USD Million (2019-2024)
  • Table 186. Middle East Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 187. Africa Nutrigenomics, by Type USD Million (2019-2024)
  • Table 188. Africa Nutrigenomics, by Application USD Million (2019-2024)
  • Table 189. Africa Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 190. North America Nutrigenomics, by Country USD Million (2019-2024)
  • Table 191. North America Nutrigenomics, by Type USD Million (2019-2024)
  • Table 192. North America Nutrigenomics, by Application USD Million (2019-2024)
  • Table 193. North America Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 194. United States Nutrigenomics, by Type USD Million (2019-2024)
  • Table 195. United States Nutrigenomics, by Application USD Million (2019-2024)
  • Table 196. United States Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 197. Canada Nutrigenomics, by Type USD Million (2019-2024)
  • Table 198. Canada Nutrigenomics, by Application USD Million (2019-2024)
  • Table 199. Canada Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 200. Mexico Nutrigenomics, by Type USD Million (2019-2024)
  • Table 201. Mexico Nutrigenomics, by Application USD Million (2019-2024)
  • Table 202. Mexico Nutrigenomics, by Techniques USD Million (2019-2024)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Nutrigenomics: by Type USD Million (2013-2018)
  • Figure 5. Global Nutrigenomics: by Application USD Million (2013-2018)
  • Figure 6. Global Nutrigenomics: by Techniques USD Million (2013-2018)
  • Figure 7. South America Nutrigenomics Share (%), by Country
  • Figure 8. Asia Pacific Nutrigenomics Share (%), by Country
  • Figure 9. Europe Nutrigenomics Share (%), by Country
  • Figure 10. MEA Nutrigenomics Share (%), by Country
  • Figure 11. North America Nutrigenomics Share (%), by Country
  • Figure 12. Global Nutrigenomics share by Players 2018 (%)
  • Figure 13. Global Nutrigenomics share by Players (Top 3) 2018(%)
  • Figure 14. Global Nutrigenomics share by Players (Top 5) 2018(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Cura Integrative Medicine (Australia) Revenue, Net Income and Gross profit
  • Figure 17. Cura Integrative Medicine (Australia) Revenue: by Geography 2018
  • Figure 18. NutraGene (United States) Revenue, Net Income and Gross profit
  • Figure 19. NutraGene (United States) Revenue: by Geography 2018
  • Figure 20. XCODE Life Science Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 21. XCODE Life Science Pvt. Ltd. (India) Revenue: by Geography 2018
  • Figure 22. Nutrigenomix (Canada) Revenue, Net Income and Gross profit
  • Figure 23. Nutrigenomix (Canada) Revenue: by Geography 2018
  • Figure 24. WellGen Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. WellGen Inc. (United States) Revenue: by Geography 2018
  • Figure 26. Genomix Nutrition Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Genomix Nutrition Inc. (United States) Revenue: by Geography 2018
  • Figure 28. Royal DSM (Netherlands) Revenue, Net Income and Gross profit
  • Figure 29. Royal DSM (Netherlands) Revenue: by Geography 2018
  • Figure 30. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 31. BASF SE (Germany) Revenue: by Geography 2018
  • Figure 32. Danone S.A (France) Revenue, Net Income and Gross profit
  • Figure 33. Danone S.A (France) Revenue: by Geography 2018
  • Figure 34. GeneSmart (United States) Revenue, Net Income and Gross profit
  • Figure 35. GeneSmart (United States) Revenue: by Geography 2018
  • Figure 36. Global Nutrigenomics: by Type USD Million (2019-2024)
  • Figure 37. Global Nutrigenomics: by Application USD Million (2019-2024)
  • Figure 38. Global Nutrigenomics: by Techniques USD Million (2019-2024)
  • Figure 39. South America Nutrigenomics Share (%), by Country
  • Figure 40. Asia Pacific Nutrigenomics Share (%), by Country
  • Figure 41. Europe Nutrigenomics Share (%), by Country
  • Figure 42. MEA Nutrigenomics Share (%), by Country
  • Figure 43. North America Nutrigenomics Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Cura Integrative Medicine (Australia)
  • NutraGene (United States)
  • XCODE Life Science Pvt. Ltd. (India)
  • Nutrigenomix (Canada)
  • WellGen Inc. (United States)
  • Genomix Nutrition Inc. (United States)
  • Royal DSM (Netherlands)
  • BASF SE (Germany)
  • Danone S.A (France)
  • GeneSmart (United States)
Additional players considered in the study are as follows:
Unilever (United Kingdom) , Genova Diagnostics (United States) , NutriGenomix, Inc. (Canada) , Metagenics, Inc. (United States) , WellGen, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation